Strategic Global Advisors, LLC Amgen Inc Transaction History

Strategic Global Advisors, LLC

$459 Million
Q1 2024

A detailed history of Strategic Global Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Strategic Global Advisors, LLC holds 10,805 shares of AMGN stock, worth $3.36 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

10,805

Previous 11,084 2.52%

Holding current value

$3.36 Million

Previous $3.19 Million 3.76%

% of portfolio

0.67%

Previous 0.74%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $75,014 - $90,552	-279 Reduced 2.52%	10,805 $3.07 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $2.03 Million - $2.29 Million	-7,930 Reduced 41.71%	11,084 $3.19 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $508,579 - $631,415	-2,326 Reduced 10.9%	19,014 $5.11 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $2.63 Million - $3.11 Million	-12,257 Reduced 36.48%	21,340 $4.74 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $668,789 - $815,142	-2,962 Reduced 8.1%	33,597 $8.12 Million

Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $163,527 - $207,781	-714 Reduced 1.92%	36,559 $9.6 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $331,527 - $373,902	-1,477 Reduced 3.81%	37,273 $8.4 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $908,766 - $1.01 Million	3,939 Added 11.32%	38,750 $9.43 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $372,978 - $412,611	1,701 Added 5.14%	34,811 $8.42 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $542,743 - $621,120	2,729 Added 8.98%	33,110 $7.45 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $1.52 Million - $1.78 Million	7,175 Added 30.92%	30,381 $6.46 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $4.14 Million - $4.59 Million	-17,711 Reduced 43.29%	23,206 $5.66 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $173,089 - $201,708	780 Added 1.94%	40,917 $10.2 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $185,221 - $220,565	-856 Reduced 2.09%	40,137 $9.23 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $788,658 - $877,052	3,361 Added 8.93%	40,993 $10.4 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $458,919 - $563,156	-2,320 Reduced 5.81%	37,632 $8.88 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $250,033 - $331,612	-1,372 Reduced 3.32%	39,952 $8.1 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $41,626 - $53,504	-220 Reduced 0.53%	41,324 $9.96 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $721,337 - $864,312	-4,143 Reduced 9.07%	41,544 $8.04 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $451,590 - $529,365	-2,709 Reduced 5.6%	45,687 $8.42 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $4.04 Million - $4.55 Million	22,318 Added 85.58%	48,396 $9.19 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $586,400 - $684,517	-3,287 Reduced 11.19%	26,078 $5.08 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $17,787 - $20,053	-96 Reduced 0.33%	29,365 $6.09 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $168,790 - $188,590	-1,000 Reduced 3.28%	29,461 $5.12 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $5.1 Million - $5.82 Million	30,461	30,461 $5.68 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Global Advisors, LLC with notifications on news.

Account

Strategic Global Advisors, LLC Amgen Inc Transaction History